Refine by
Depression Treatment Articles & Analysis
6 news found
Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of life. ...
Neurolief Ltd., a neurotechnology innovator, today announced enrollment of the first patient in its pivotal clinical study evaluating Relivion® DP for the treatment of major depressive disorder (MDD). The Relivion DP is the first non-invasive, multi-channel brain neuromodulation system for at home treatment of neurological and ...
This agreement between the companies will grant Bexson access to the use of Stevanato’s wearable delivery system - a customized version of the SG EZ-be Pod - to develop new therapeutics to treat a wide range of mental health conditions, including treatment-resistant depression and PTSD. Since 2020, Stevanato Group and Bexson have worked to optimize the ...
According to a Mashable article on a study of the efficacy of VR treatment for depression and anxiety, “This type of immersive therapy is a viable and potentially revolutionizing method to treat certain mental health conditions. A blend of VRET and well–established practices in mental health treatment can both augment and enhance ...
Relmada intends to use the net proceeds from the offering, together with existing cash, cash equivalents, and short-term investments, to fund research and development activities for its clinical development programs related to Relmada's lead product candidate, REL-1017 (esmethadone), which is being developed as a rapidly acting, oral agent for the treatment of ...
Relmada intends to use the net proceeds from the offering, together with existing cash, cash equivalents, and short-term investments, to fund research and development activities for its clinical development programs related to Relmada's lead product candidate, REL-1017 (esmethadone), which is being developed as a rapidly acting, oral agent for the treatment of ...